John S Tillinghast

Title: Discovering Innovations by John S. Tillinghast

Introduction

John S. Tillinghast, an innovative inventor based in Menlo Park, California, has made significant contributions to the field of biotechnology. With a noted patent under his name, his work focuses on advancing our understanding of novel polypeptides and polynucleotides.

Latest Patents

John S. Tillinghast holds a patent for "Methods and materials relating to novel von Willebrand/Thrombospondin-like polypeptides and polynucleotides." This patent details an invention that introduces novel polynucleotides and polypeptides encoded by such polynucleotides and their variants. Specifically, the polynucleotides are derived from a cDNA library from the human fetal brain, identified by Hyseq clone number 15258924. His invention also encompasses vectors for producing these innovative polypeptides and antibodies that are specific to them.

Career Highlights

John is affiliated with Hyseq, Inc., where he leverages his expertise to drive research forward in the field of genetic and biomedical innovation. His patent reflects his commitment to developing technologies that can have significant implications in medicine and healthcare.

Collaborations

Throughout his career at Hyseq, John S. Tillinghast has collaborated with esteemed colleagues, including Bryan J. Boyle and Nancy K. Mize. Their collective efforts have contributed to advancements in understanding the complexities of genetics and the development of novel therapeutic approaches.

Conclusion

John S. Tillinghast's work exemplifies the spirit of innovation and the pursuit of knowledge within biotechnology. His patent serves as a testament to his contributions and the potential impact on future research and medical treatments. As he continues to work within the industry, his inventions remain pivotal in the ongoing evolution of science and technology.